Register entry

Millicent US, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Live patents
3
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 5 human prescription drug, 1 drug for further processing. By marketing category: NDA 5, DRUG FOR FURTHER PROCESSING 1.

Dosage formNDCs
insert2
kit2
ring2
RouteNDCs
vaginal4
Labeller name on the listingNDCs
millicent us, inc.6
Exclusivity

Patents and exclusivities

3
PatentProductCoversExpiry
8629129INTRAROSAprasteroneproductAug 2028
8957054INTRAROSAprasteroneuseJan 2030
8268806INTRAROSAprasteroneproductMar 2031
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
FEMLYVNorethindrone Acetate/Ethinyl Estradiolkit72495-601NDA
Femringestradiol acetatering, vaginal72495-201NDA
Femringestradiol acetatering, vaginal72495-202NDA
IntrarosaPrasteroneinsert, vaginal72495-401NDA
IntrarosaPrasteroneinsert, vaginal72495-501NDA
-norethindrone acetate/ethinyl estradiolkit72495-600DRUG FOR FURTHER PROCESSING
Compare

Other companies listing prasterone

Enquiry

Common questions

Is Millicent US, Inc. FDA approved?
Millicent US, Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Millicent US, Inc. make?
6 products are listed under Millicent US, Inc. in the openFDA NDC Directory, most often as insert; kit; ring. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.